Tag archief: English Only

Gilead Presents New Data in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2019

— New Proof-of-Concept Data for Combination of Investigational FXR Agonist Cilofexor and ACC Inhibitor Firsocostat in NASH — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc....

As Brazil’s New President Jair Bolsonaro Takes the Top Spot as the Most Engaged World Leader on Facebook, Others Pay to Play to Make an Impact on the Platform

BCW Study Finds 50 Leaders Have Paid to Promote Their Posts, Including U.S. President Donald Trump Who Has Promoted More Than 50,000 Posts on Facebook...

Gilead Announces New Grant Programs Supporting Investigator-Sponsored Research in Liver Diseases

– Funding will Support Research to Advance Scientific Understanding and Improve Patient Care in Viral Hepatitis, Co-Infection, Nonalcoholic Steatohepatitis and Primary Sclerosing Cholangitis – FOSTER...

Philip Morris International Presents IQOS World Revealed by Alex Chinneck at Milan Design Week 2019

Unique Collaboration Brings Together Advanced Technology and a Visionary Artist LAUSANNE, Switzerland–(BUSINESS WIRE)– Philip Morris International Inc. (PMI) (NYSE: PM) today presents IQOS World revealed...

Boehringer Ingelheim Launches the First-Ever Registered Stem Cell-Based Veterinary Medicine

European Commission has granted marketing authorisation for the first stem cell-based product in animal health Arti-Cell® Forte is a unique ready-to-use solution for the treatment...

Crown Media Family Networks to Deliver Growing Hallmark Channel Lineup to US Homes with SES

LUXEMBOURG–(BUSINESS WIRE)– TV Homes across the U.S. will continue to receive Crown Media Family Networks’ channels because of an important renewal agreement with SES, the...

Philip Morris International Enters the ‘Year of Unsmoke’—Calls on All Those Who Can Empower a Smoke-Free Future

Eight out of 10 (79 percent) people globally, support PMI working with governments, regulators and public health experts to phase-out cigarettes in favor of smoke-free...

Celltrion Partners with the Canadian Biotech Company, iProgen Biotech to Develop a Series of Novel ADCs

Celltrion signs a partnership deal with the Canada-based iProgen Biotech Inc. to bolster its pipeline for novel biotherapeutics. The deal aims to co-develop up to...

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

– Filing Supported by Data Demonstrating Non-inferiority Compared to Truvada® Coupled with Bone and Renal Safety Advantages in People at Risk of Sexually Acquired HIV...

O3b Satellites Roar into Space, Scaling SES’s MEO Constellation

Four additional satellites will seamlessly scale SES’s MEO constellation which has positively impacted millions of people with low-latency, high-performance data connectivity services, and mark transition...

SES Shareholders Approve All Resolutions at Annual General Meeting

Dividend of EUR 0.80 per A-share approved LUXEMBOURG–(BUSINESS WIRE)– SES (Euronext Paris and Luxembourg Stock Exchange: SESG) held its Annual General Meeting (AGM) today in...

Samsung’s Multi-Mode Exynos Chipsets Help Bring the 5G Era to Mobile Consumers

Samsung’s 5G modem and RF chips are currently in mass production for the latest premium mobile devices SEOUL, South Korea–(BUSINESS WIRE)– Samsung Electronics Co., Ltd.,...

AVENIR GLOBAL Continues to Build Global Powerhouse of Specialist Communications Firms with Acquisition of Hanover

Combined operations rank among top U.K. and European consultancies MONTREAL & LONDON–(BUSINESS WIRE)– AVENIR GLOBAL, a Montreal-based holding and management company of public relations and...

Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma

OXFORD, England & CONSHOHOCKEN, Pa.–(BUSINESS WIRE)– Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that the U.S. Food and Drug Administration (FDA) has...

CSC Pharmaceuticals Announces the Launch of the Innovative Migraine and Pain Treatment Developed by APR Applied Pharma Research

BALERNA, Switzerland–(BUSINESS WIRE)– APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other pain areas is now...